# Beau Seil

> Beau Seil is a seed investor at Patamar Capital (San Francisco) backing Apps and FinTech. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Patamar Capital](https://shizune.co/investors/profile/patamar-capital)
- Location: San Francisco, United States
- Total investments: 3
- Last investment: Feb 2023
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/beauseil/

Beau Seil is a seed investor at Patamar Capital in San Francisco focused on Apps and FinTech. Beau is a co-founder and managing partner of Patamar Capital and the Livelihood Impact Fund. He is currently the board chair of RUMA (Indonesia), a board member of Kalibrr (Philippines), and actively monitors Patamar Capital's investments in MobiVi (Vietnam) and Trust Circle (Vietnam).Immediately prior to the launch of Patamar Capital,Beau was a Principal at Capital Impact, where he worked extensively on the Sorenson Housing Opportunity Fund, a private equity fund focused on developing India’s affordable housing ecosystem, and spent significant time in China working on multiple projects and leading Capital Impact’s outreach in the PRC.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Apps | 1 | 33% |
| FinTech | 1 | 33% |
| mHealth | 1 | 33% |
| Big Data | 1 | 33% |
| Health Care | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Series B | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Singapore | 1 | 33% |
| Philippines | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SwipeRx | mClinica develops mobile platforms that strengthen the pharmaceutical supply chain, generate data, improve patient adherence to medication, and build the capacity of the pharmacy workforce. Since 2017, mClinica has connected 150,000 pharmacy professionals and 40,000 pharmacies through a single digital channel. Their users reach approximately 150million patients each month. mClinica currently operates across Indonesia, Philippines, Vietnam, Cambodia, Thailand, Malaysia, and Singapore with capacity for expansion. Their team is composed of over 120 team members including experts in public health, data science, and pharmacy. mClinica is supported by impact investors like the Global Innovation Fund (backed by USAID, UKAID, DFAT, Swedish Government, and the Omidyar Network) and Patamar Capital (formerly Unitus Impact) as well as other investors from the US, Europe, and Asia. mClinica implements projects both digitally and on the ground to connect the world’s pharmacies and transform global health. mClinica follows a social enterprise business model in which they seek double-bottom line returns – maximizing both financial returns and social impact.mClinica’s rapid growth and success is increasingly recognized. mClinica was the recipient of the Data Driven Apps Award of the World Government Summit in 2019, USAID-FHI360 Data for Resilience Award, Pierre Fabre Foundation Prize for eHealth Innovation, and Hack Osaka. The company has consistently been recognized as one of the most innovative startups in healthcare in Asia Pacific. | $10M | Series B | Feb 09, 2023 |  |
| Peddlr | Jumpstarting Philippine Micro and Small businesses to digital world. Peddlr is a free POS app for micro and small entrepreneurs in the Philippines and South East Asia that helps them earn more and better manage their businesses. | $4.3M | Seed | Feb 05, 2022 |  |
| SwipeRx | mClinica develops mobile platforms that strengthen the pharmaceutical supply chain, generate data, improve patient adherence to medication, and build the capacity of the pharmacy workforce. Since 2017, mClinica has connected 150,000 pharmacy professionals and 40,000 pharmacies through a single digital channel. Their users reach approximately 150million patients each month. mClinica currently operates across Indonesia, Philippines, Vietnam, Cambodia, Thailand, Malaysia, and Singapore with capacity for expansion. Their team is composed of over 120 team members including experts in public health, data science, and pharmacy. mClinica is supported by impact investors like the Global Innovation Fund (backed by USAID, UKAID, DFAT, Swedish Government, and the Omidyar Network) and Patamar Capital (formerly Unitus Impact) as well as other investors from the US, Europe, and Asia. mClinica implements projects both digitally and on the ground to connect the world’s pharmacies and transform global health. mClinica follows a social enterprise business model in which they seek double-bottom line returns – maximizing both financial returns and social impact.mClinica’s rapid growth and success is increasingly recognized. mClinica was the recipient of the Data Driven Apps Award of the World Government Summit in 2019, USAID-FHI360 Data for Resilience Award, Pierre Fabre Foundation Prize for eHealth Innovation, and Hack Osaka. The company has consistently been recognized as one of the most innovative startups in healthcare in Asia Pacific. |  | Series A | Feb 15, 2017 |  |

3 of 3 investments shown.

## Co-investors
- [500 Southeast Asia](https://shizune.co/investors/profile/500-durians-2) — VC Fund, 1 deal together
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 1 deal together
- [Cercano Management](https://shizune.co/investors/profile/cercano-management) — VC Fund, 1 deal together
- [Crestone Venture Capital](https://shizune.co/investors/profile/crestone-venture-capital) — VC Fund, 1 deal together
- [Endeavor Catalyst](https://shizune.co/investors/profile/endeavor-catalyst) — VC Fund, 1 deal together
- [Foxmont Capital Partners](https://shizune.co/investors/profile/foxmont-capital-partners) — VC Fund, 1 deal together

## About Patamar Capital

VC Fund · Singapore, Singapore

Patamar Capital is emerging Asia’s leading impact venture capital firm aggressively driving early-stage investments into tech-led companies. Since 2011, our vision is to change the future of South and Southeast Asia by making technology accessible to transform the everyday lives of the emerging middle class. The Fund will primarily invest incompanies across five industry sectors: Financial Services, Education, Health, Supply Chain Services, and Agriculture. Our early-stage investments are dispersed to tech entrepreneurs harnessing the economic power of the emerging middle-class consumers. By addressing market linkage inefficiencies, the Fund’s investments will seek to unlock economic value not only for Limited Partners, but also for low-income communities who are disproportionately affected by these inefficiencies. We continue to drive economic impact and yield great financial returns.

5 contacts available at Patamar Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Beau Seil | Managing Partner | https://shizune.co/investors/profile/beau-seil |
| Dondi Hananto | Partner | https://shizune.co/investors/profile/dondi-hananto |
| Geoff "Chester" Woolley | Partner | https://shizune.co/investors/profile/geoff-chester-woolley |
| Lee FitzGerald | Managing Partner | https://shizune.co/investors/profile/lee-fitzgerald |
| Ryan Zoradi | Principal | https://shizune.co/investors/profile/ryan-zoradi |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Beau Seil invest in?

Beau Seil invests primarily in Apps, FinTech and mHealth startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Beau Seil last invest?

The most recent investment recorded for Beau Seil closed in Feb 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co